C WorldWide Thematic Specialist Morten Springborg says his firm has outperformed by taking a much longer-term approach than is usual for money managers.
By Dominic Chopping Novo Nordisk has agreed to acquire a drug being developed to treat uncontrolled hypertension, which could also help cardiovascular and.
Novo Nordisk A/S said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is a pill that also.
By Dominic Chopping Novo Nordisk raised its full-year guidance as sales of its blockbuster obesity and weight-loss drugs continue to surge, particularly in.